Evidence map›Paper›PMID 42588617›Full record

ReviewCancers2026

Selected Blood-Accessible Biomarkers in Prostate Cancer Radiotherapy: A PRISMA-ScR Timing-Window Framework Beyond PSA.

Miloš Grujić, Barbara Alicja Jereczek-Fossa, Ivan Jovanović, Marija Živković Radojević, Giulia Marvaso, Katarina Krasić, Katarina Janković, Marija Peulić, Federico Mastroleo, Łukasz Kuncman and 3 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Miloš GrujićClinic of Radiation Oncology, University Clinical Center Kragujevac, 34000 Kragujevac, Serbia.ORCID 0009-0000-9552-8649
Barbara Alicja Jereczek-FossaDepartment of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.ORCID 0000-0001-8151-3673
Ivan JovanovićCenter for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.ORCID 0000-0002-1169-2378
Marija Živković RadojevićClinic of Radiation Oncology, University Clinical Center Kragujevac, 34000 Kragujevac, Serbia.ORCID 0000-0003-2146-3381
Giulia MarvasoDepartment of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.ORCID 0000-0002-5339-8038
Katarina KrasićClinic of Radiation Oncology, University Clinical Center Kragujevac, 34000 Kragujevac, Serbia.
Katarina JankovićClinic of Radiation Oncology, University Clinical Center Kragujevac, 34000 Kragujevac, Serbia.ORCID 0009-0002-7891-7962
Marija PeulićDepartment of Oncology, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.
Federico MastroleoDepartment of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.ORCID 0000-0001-6580-6767
Łukasz KuncmanDepartment of Radiotherapy, Medical University of Lodz, 93-513 Lodz, Poland.ORCID 0000-0003-3568-269X
Vladan MutavdžićDepartment of Oncology, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.ORCID 0009-0007-3761-8671
Milica MihajlovićFaculty of Medicine, University of Niš, 18108 Niš, Serbia.
Neda MilosavljevićClinic of Radiation Oncology, University Clinical Center Kragujevac, 34000 Kragujevac, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkersgalectinsinterleukin-6prostate cancerradiotherapytestosteroneγ-H2AX

Identifiers

PMID42588617
PMCPMC13463946

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.